Skip to content
Politically.com Search all
Menu

Louisiana 2026

HB 870

INSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)

Open original source Back to bills
Source: Open States / PluralLatest available (refresh failed). Last refreshed: 2026-09-09 19:11:02 UTC.

Official record

Measure details

Jurisdiction
Louisiana
Session
2026
Chamber
lower
Classification
bill
Subjects
Not supplied
Introduced / first action
2026-02-27 00:00:00

Sponsors

Source-supplied history

Actions

  1. Signed by the Governor. Becomes Act No. 907.

    became-law, executive-signature

  2. Effective date: 08/01/2026.

  3. Sent to the Governor for executive approval.

    executive-receipt

  4. Enrolled and signed by the Speaker of the House.

    enrolled

  5. Signed by the President of the Senate.

  6. Conference Committee Report read, roll called, yeas 94, nays 0. The Conference Committee Report was adopted.

  7. Notice House adopted the Conference Committee Report.

  8. Conference Committee Report read; adopted by a vote of 36 yeas and 0 nays.

  9. Notice of Senate adoption of Conference Committee Report.

  10. Conference Committee report received. Lies over under the rules.

  11. Conference committee report received.

  12. Scheduled for floor debate on 05/312026.

  13. House conferees appointed: Turner, Firment, and Miller.

  14. Notice House Conference Committee members appointed.

  15. Read by title, roll called, yeas 99, nays 0, Senate amendments rejected, conference committee appointment pending.

  16. Notice House rejected the Senate amendments.

  17. Senate conference committee members appointed: Talbot, Bass, and Harris.

  18. Notice of Senate conferees appointed.

  19. Scheduled for concurrence on 05/26/2026.

  20. Received from the Senate with amendments.

    receipt

  21. Rules suspended. Called from the Calendar.

  22. Senate floor amendments read and adopted. Read by title, passed by a vote of 33 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.

    passage

  23. Rules suspended.

  24. Read by title and returned to the Calendar, subject to call.

  25. Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.

    reading-3

  26. Committee amendments read and adopted. Read by title and referred to the Legislative Bureau.

  27. Reported with amendments.

    committee-passage-favorable

  28. Read second time by title and referred to the Committee on Insurance.

    reading-2, referral-committee

  29. Received in the Senate. Read first time by title and placed on the Calendar for a second reading.

    reading-1

  30. Called from the calendar.

  31. Read third time by title, amended, roll called on final passage, yeas 96, nays 0. Finally passed, title adopted, ordered to the Senate.

    passage

  32. Read by title, returned to the calendar.

  33. Notice given.

  34. Scheduled for floor debate on 04/13/2026.

  35. Scheduled for floor debate on 04/09/2026.

  36. Read by title, amended, ordered engrossed, passed to 3rd reading.

    reading-3

  37. Reported with amendments (10-0).

    committee-passage-favorable

  38. Read by title, under the rules, referred to the Committee on Insurance.

    referral-committee

  39. Prefiled.

    filing

  40. Under the rules, provisionally referred to the Committee on Insurance.

    referral-committee

  41. First appeared in the Interim Calendar on 2/27/2026.

Documents and versions

Official links

When supplied by the API

Related measures

No resolvable related measure is supplied.